Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Noxopharm Ltd. ( (AU:NOX) ) is now available.
Noxopharm Limited has significantly reduced its holding in Nyrada Inc., decreasing its voting power from 18.60% to 5.13%. This change in substantial holding may impact Nyrada’s shareholder dynamics and influence within the company, potentially affecting its strategic decisions and market perception.
More about Noxopharm Ltd.
Nyrada Inc. is a biotechnology company specializing in the discovery and development of innovative small-molecule therapies. The company focuses on targeting Transient Receptor Potential Canonical (TRPC) ion channels, with its lead candidate, NYR-BI03, currently undergoing a Phase I clinical trial for neuroprotection and cardioprotection. Nyrada is incorporated in Delaware, USA.
Average Trading Volume: 93,059
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$20.46M
For a thorough assessment of NOX stock, go to TipRanks’ Stock Analysis page.